BioCubaFarma and ASEAN share experience on Covid  19

BioCubaFarma and ASEAN share experience on Covid 19

Both parties reported on the strategies to contain and treat the disease and the respective vaccination rates, as well as the effectiveness and safety of our vaccines, the Cuban entity announced on the social network Twitter.

The participation of renowned scholars from that island, he added, reaffirms the priority the country gives to relations and cooperation with the regional bloc and its 10 member countries (Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam).

Jeffery Lawrence Cutter, expert from the Singapore Ministry of Health, closed the event via videoconference, acknowledging the importance and usefulness of the information and suggestions transmitted by the Cuban specialists.

On previous occasions, ASEAN has reiterated its support for the Caribbean nation against the US-imposed blockade and denounced the negative impact of unilateral action.

Amidst this intensified panorama, this nation caught the attention of international media when, in July 2021, it announced Abdala, the first vaccine against Covid-19 in Latin America.

It also produced Soberana 02, Soberana Plus and is working on candidate Soberana 01 and Mambisa, a nasal formula designed to boost immunity against the disease.

So far, it is the international leader in the rate of full immunization applied per 100 inhabitants and has kept the SARS-CoV-2 virus under control in recent months due to the strategy pursued.

Factors that explain the Cuban difference from Ómicron to the world include three-dose immunization for 90 percent of the population and a booster shot for more than 60 percent of it.

Cuba was the first state to vaccinate its pediatric segment against Covid-19, allowing children and young people to go into the classroom with greater protection.

Its immunogens are safe and without serious side effects, according to successful clinical trials and administrations conducted even in a dozen countries.